Video | Agriculture | Confidence | Economy | Energy | Employment | Finance | Media | Property | RBNZ | Science | SOEs | Tax | Technology | Telecoms | Tourism | Transport | Search

 

GE Healthcare to Partner with Dunedin-Based Oritain

GE Healthcare to partner with Dunedin-based Oritain

Auckland - Dunedin-based forensics expert Oritain is announcing its partnership with global medical technology provider GE Healthcare, and their début launch of an independent test-based traceability programme to authenticate the country of origin of Fetal Bovine Serum (FBS[i]).

Oritain CEO Grant Cochrane says that Oritain’s Scientific Traceability method is unique.

“Scientific Traceability measures the naturally-occurring chemical elements that exist within the serum itself as a result of the particular environment the cows are being raised in. With FBS samples obtained from GE manufacturing sites all over the world, we have analyzed each one to create a unique fingerprint of origin for sera that comes from the USA, Australia and New Zealand.

“This cannot be changed or tampered with in any way without detection, as we are dealing with concentrations in the parts per million across more than 20 different variables,” says Cochrane. “Our authentication is unique in the fact that it does not rely on paper or labels, but rather verifies the origin of the product itself.

Morgan Norris, General Manager for Upstream and Cell Culture, GE Healthcare Life Sciences, says that the country of origin is important - especially when FBS is used in biomanufacturing.

“Different countries of origin present different risk levels for a range of virus contamination, and using serum that we know to be from low-risk countries is a top priority for our clients,” he says.

GE Healthcare is already traceability-certified by the International Serum Industry Association (ISIA), but to ensure that premium raw serum from Australia, New Zealand and the United States is indeed from that country of origin, GE will now put its sera products through a testing process that goes beyond industry-standard traceability practices.

FBS is used to manufacture vaccines that protect people from a variety of diseases. We want to ensure that our customers can access high-quality products with the lowest risk possible when producing their vaccines and biopharmaceuticals. This test-based traceability is another tool we have to assure this,” says Norris.

“By partnering with Oritain, we are committing to supply our customers with products of exceptional quality and integrity,” he says.

Cochrane says that Oritain’s country of origin verification service for FBS products means greater authenticity and trust for GE’s clients, as it minimizes the likelihood of product fraud or counterfeiting in the supply chain in high-risk countries. “We are delighted to be providing proof of origin services for these GE Healthcare products that are making the world a safer and healthier place,” he says.

With GE’s new testing programme, Oritain will perform independent testing of batch samples of FBS from Australia, New Zealand and the United States. Customers will then be able to retrieve an independent verification certificate linked to the serum lot that they have purchased, by entering the lot number found on the bottle marked with Oritain’s proprietary Trustmark and QR code on this website: http://oritain.com/gehealthcare/


ENDS


About Oritain

Oritain is a global leader in using forensic science to determine product provenance. It exists to protect the reputations of its customers by identifying and mitigating well-known supply chain risks. The Oritain difference means the ability to verify origin using the naturally occurring chemical fingerprint of products themselves, not through packaging or labels. Packaging has proven unreliable and is very susceptible to counterfeiting. By testing what’s inside the actual products, Oritain can offer a robust authentication solution for businesses. Oritain is a private company with offices in Dunedin and London, with close ties to the University of Otago. Founded in 2008, Oritain works with some of New Zealand’s leading exporters as well as global companies to protect their brands from product fraud in markets all around the world. For more information, go to www.oritain.com

About GE Healthcare
GE Healthcare provides transformational medical technologies and services to meet the demand for increased access, enhanced quality and more affordable healthcare around the world. GE (NYSE: GE) works on things that matter - great people and technologies taking on tough challenges. From medical imaging, software & IT, patient monitoring and diagnostics to drug discovery, biopharmaceutical manufacturing technologies and performance improvement solutions, GE Healthcare helps medical professionals deliver great healthcare to their patients. For more information about GE Healthcare, visit our website at www.gehealthcare.com.

________________________________________

[i] FBS is a cell growth supplement used in the manufacturing of biopharmaceuticals and vaccines for human health and veterinary purposes, as well as in basic research and drug discovery. Serum plays an important role in the cell-based production of high-quality vaccines and therapeutics for people and animals around the world.


© Scoop Media

 
 
 
Business Headlines | Sci-Tech Headlines

 

Manawatu-Whanganui Projects: PGF Top-Up To Rural Broadband Roll-Out

The government has effectively raided the $3 billion Provincial Growth Fund to top up the budget for the second phase of its rural broadband initiative, filling in mobile 'black spots' and ensuring broadband is available to marae that don't have access now. More>>

ALSO:

Other Windy Cities: Auckland-Chicago Named A Top 10 ‘Most Exciting’ New Route

The inclusion of Auckland-Chicago on Lonely Planet’s Where to fly in 2019? The 10 most exciting new flight routes list comes just two weeks before Air New Zealand prepares to celebrate its inaugural flight to Chicago’s O’Hare International Airport on 30 November. More>>

Deadly Strain: ESR Ups Its Reporting On Meningococcal Disease

The increasing number of cases of Group W Meningococcal disease (MenW) has prompted ESR to increase its reporting on the disease to the Ministry of Health. ESR has upped its reporting to weekly. More>>

ALSO:

Very Small Things: "Game-Changing" 3D Printing Technology Launched

New Zealand microfabrication researchers Andrea Bubendorfer and Andrew Best, the co-inventors of a new way of fabricating very small things with Laminated Resin Printing (LRP), are part of Callaghan Innovation’s MicroMaker3D team launching the new patent pending technology in the US this week. More>>

ALSO: